×
For best experience we recommend to activate Javascript in your browser.
UBAC1 antibody (C-Term)
The Rabbit Polyclonal anti-UBAC1 antibody has been validated for WB, ELISA, IHC and FACS. It is suitable to detect UBAC1 in samples from Human.
Quick Overview for UBAC1 antibody (C-Term) (ABIN2381090)
Target
See all UBAC1 Antibodies
UBAC1
(UBA Domain Containing 1 (UBAC1))
Reactivity
All reactivities for UBAC1 antibodies
Human
Host
All hosts for UBAC1 antibodies
Rabbit
Clonality
All clonalities for UBAC1 antibodies
Polyclonal
Conjugate
All conjugates for UBAC1 antibodies
This UBAC1 antibody is un-conjugated
Application
All applications for UBAC1 antibodies
Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Flow Cytometry (FACS)
Product Details anti-UBAC1 Antibody
(hide)
Binding Specificity
All epitopes for UBAC1 antibodies
AA 272-302, C-Term
Cross-Reactivity
Human
Cross-Reactivity (Details)
Calculated cross reactivity: Hu
Characteristics
UBAC1, CT (UBAC1, GBDR1, KPC2, UBADC1, Ubiquitin-associated domain-containing protein 1, E3 ubiquitin-protein ligase subunit KPC2, Glialblastoma cell differentiation-related protein 1, Kip1 ubiquitination-promoting complex protein 2)
Purification
Purified by Protein A affinity chromatography.
Immunogen
UBAC1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 272-302 amino acids from the C-terminal region of human UBAC1.
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working conditions should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
-20°C
Target Details for UBAC1
(hide)
Target
UBAC1
(UBA Domain Containing 1 (UBAC1))
Alternative Name
UBAC1
NCBI Accession
NP_057256
UniProt
Q9BSL1
Recently viewed
(hide)
Chat with us , powered by LiveChat